The documents listed directly beneath the Offering Memorandum (the “Offering Memorandum”) are incorporated by reference into the Offering Memorandum, as in effect from time to time, relating to the U.S. medium term notes program of Société Générale. 

 

   OFFERING MEMORANDUM
 
03/18/2024 SG Offering Memorandum dated March 18, 2024
05/31/2023 SG Offering Memorandum dated May 31, 2023


   SUPPLEMENTS TO THE OFFERING MEMORANDUM
 
First Supplement to SG Offering Memorandum dated March 18, 2024
First Supplement to SG Offering Memorandum dated May 31, 2023


   PRODUCT SUPPLEMENTS
 
03/18/2024 Equity-Linked Notes Product Supplement
03/18/2024 ETF-Linked Notes Product Supplement
03/18/2024 Index-Linked Notes Product Supplement
03/18/2024 Rate-Linked Notes Product Supplement
03/18/2024 Credit-Linked Notes Product Supplement
03/18/2024 Commodity-Linked Notes Product Supplement
03/18/2024 Currency-Linked Notes Product Supplement
05/31/2023 Equity-Linked Notes Product Supplement
05/31/2023 ETF-Linked Notes Product Supplement
05/31/2023 Index-Linked Notes Product Supplement
05/31/2023 Rate-Linked Notes Product Supplement
05/31/2023 Credit-Linked Notes Product Supplement
05/31/2023 Commodity-Linked Notes Product Supplement
05/31/2023 Currency-Linked Notes Product Supplement


   ANNUAL REPORT & QUARTERLY RESULTS OF SOCIETE GENERALE GROUP (THE "GROUP") AND UPDATES THERETO; PRESS RELEASES PUBLISHED UNDER REGULATED INFORMATION
 
ANNUAL REPORTS
3rd Amendment to 2024 Universal Registration Document
2nd Amendment to 2024 Universal Registration Document
1st Amendment to 2024 Universal Registration Document
2024 Universal Registration Document
3rd Amendment to 2023 Universal Registration Document
2nd Amendment to 2023 Universal Registration Document
1st Amendment to 2023 Universal Registration Document
2023 Universal Registration Document


QUARTERLY RESULTS
10/31/2024 Third Quarter 2024
08/01/2024 Second Quarter 2024
05/03/2024 First Quarter 2024
02/08/2024 Fourth Quarter 2023
11/03/2023 Third Quarter 2023
08/03/2023 Second Quarter 2023
05/12/2023 First Quarter 2023


   LIBOR TRANSITION UPDATE
 
USD LIBOR REPLACEMENT NOTICES
Notice for Callable Conditional Coupon Worst-Of Yield Notes
Notice for Fixed To Capped Floating Rate Notes
Notice for Hybrid Callable Worst-Of Range Accrual Non-Principal Protected Notes




   LIBOR CMS FALLBACK UPDATE
 
List of Outstanding US Law-Governed USD LIBOR CMS Instruments Subject to the USD LIBOR CMS Fallback Notices



USD LIBOR CMS FALLBACK NOTICES (INITIAL FALLBACK TO DEALER QUOTATIONS)

ISSUER: SOCIETE GENERALE
15-Year Leveraged CMS Spread Notes
Callable CMS Spread Call Notes
CMS Callable Conditional Coupon Worst-Of Yield Notes
CMS Callable Non-Inversion Range Accrual Notes
CMS Fixed to Floating Notes
CMS Hybrid Callable Range Accrual and Callable Daily Range Accrual Notes (CMS Base Rate Observation)
CMS Hybrid Callable Range Accrual and Callable Daily Range Accrual Notes (Daily CMS Observation)
CMS Hybrid Range Accrual Notes

ISSUER: SG STRUCTURED PRODUCTS, INC.
SGSP 15-Year Leveraged CMS Spread Notes
SGSP 20-Year Callable Leverage CMS Spread Notes
SGSP Callable CMS Spread Notes


USD LIBOR CMS FALLBACK NOTICES (INITIAL FALLBACK TO CALCULATION AGENT SELECTION OF SUCCESSOR RATE)

ISSUER: SOCIETE GENERALE
Callable CMS Spread Notes
CMS Hybrid Callable Range Accrual and Callable Daily Range Accrual Notes (Daily CMS Observation)
CMS Hybrid Callable Range Accrual and Callable Daily Range Accrual Notes (CMS Base Rate Observation)


Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Offering Memorandum.

The Notes and the Guarantee described in the Offering Memorandum have not been, and will not be, registered under the Securities Act of 1933, as amended (the “Securities Act”) and, except as specified otherwise in the applicable Offering Memorandum Supplement, are being offered pursuant to the exemption from the registration requirements thereof contained in Section 3(a)(2) of the Securities Act.
The Notes and the Guarantee may also, in conjunction with or independently from the exemption from registration provided by Section 3(a)(2) of the Securities Act, be offered and sold (i) in the United States, only to persons who are “Accredited Investors” (as defined in Rule 501 of Regulation D, as amended, under the Securities Act) in reliance on Section 4(a)(2) of the Securities Act (the “Section 4(a)(2) Notes”), or (ii) in the United States, to “Qualified Institutional Buyers” (as defined in Rule 144A, as amended, under the Securities Act) in reliance on Rule 144A under the Securities Act (“Rule 144A Notes”) or (iii) outside the United States, in reliance on Regulation S under the Securities Act (“Regulation S Notes”). The Section 4(a)(2) Notes, Rule 144A Notes or Regulation S Notes, as applicable, have not been, and will not be, registered under the Securities Act, or the state securities laws of any state of the United States or the securities laws of any other jurisdiction. The Section 4(a)(2) Notes, Rule 144A Notes or Regulation S Notes, as applicable, may not be offered, sold, pledged or otherwise transferred except in a transaction exempt from, or not subject to, the registration requirements of the Securities Act. Prospective purchasers are hereby notified that (i) the seller of the Section 4(a)(2) Notes may be relying on the exemption from provisions of Section 5 of the Securities Act contained in Section 4(a)(2) thereof and (ii) the seller of Rule 144A Notes may be relying on the exemption from provisions of Section 5 of the Securities Act provided by Rule 144A. For a description of certain restrictions on transfers and resales of the Section 4(a)(2) Notes, Rule 144A Notes and Regulation S Notes, see the section entitled “Notice to Investors” in the Offering Memorandum.
The Issuer has not been registered under the Investment Company Act of 1940, as amended.
None of the Securities and Exchange Commission, any state securities commission or regulatory authority or any other United States, French or other regulatory authority has approved or disapproved of the Notes or the Guarantee or passed upon the accuracy or adequacy of the Offering Memorandum or any applicable Offering Memorandum Supplement. Any representation to the contrary is a criminal offense in the United States. Under no circumstances shall the Offering Memorandum and/or any applicable Offering Memorandum Supplement constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these Notes or the Guarantee, in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification under the securities laws of any such jurisdiction.
THE NOTES CONSTITUTE UNCONDITIONAL LIABILITIES OF THE ISSUER, AND THE GUARANTEE CONSTITUTES AN UNCONDITIONAL OBLIGATION OF THE GUARANTOR. THE NOTES AND THE GUARANTEE ARE NOT INSURED OR GUARANTEED BY THE FEDERAL DEPOSIT INSURANCE CORPORATION, THE BANK INSURANCE FUND OR ANY U.S. OR FRENCH GOVERNMENTAL OR DEPOSIT INSURANCE AGENCY.
banner sgcib

Important Legal Information | Cookie policy © , SOCIÉTÉ GÉNÉRALE, U.S. Medium-Term Note Program.
All rights reserved.